IMR Press / FBS / Volume 8 / Issue 1 / DOI: 10.2741/S447

Frontiers in Bioscience-Scholar (FBS) is published by IMR Press from Volume 13 Issue 1 (2021). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on as a courtesy and upon agreement with Frontiers in Bioscience.


Glucometabolic disease in the kidney transplant patient

Show Less
1 Weill Cornell Medical College at Houston Methodist Hospital, Houston, Texas
2 Boston University School of Medicine, Department of Medicine, Section of Endocrinology, Boston, Massachusetts
3 Harvard Medical School, Brigham and Women’s Hospital, Department of Medicine, Division of Endocrinology, Diabetes and Hypertension, Boston, Massachusetts

*Author to whom correspondence should be addressed.

Academic Editors: Ogo Egbuna, Jean Francis

Front. Biosci. (Schol Ed) 2016, 8(1), 67–78;
Published: 1 January 2016

The comprehensive care of the kidney transplant (KT). patient includes a broad clinical assessment to detect and stage metabolic disease both before and after transplantation. In this review, the metabolic consequences of KT in both the short and long term will be explored in the context of new data and a synthesis proposed based upon what has been studied for over two decades. A review of the changes in epidemiology introduces a discussion of the current state of the literature for the diagnosis and management of diabetes after KT, obesity and the metabolic syndrome.

Metabolic syndrome
Back to top